A Combined Chronic Low-Dose Soluble Epoxide Hydrolase and Acetylcholinesterase Pharmacological Inhibition Promotes Memory Reinstatement in Alzheimer's Disease Mice Models
Alzheimer's disease (AD) is a progressive neurological disorder with multifactorial and heterogeneous causes. AD involves several etiopathogenic mechanisms such as aberrant protein accumulation, neurotransmitter deficits, synaptic dysfunction and neuroinflammation, which lead to cognitive decli...
Saved in:
Main Authors: | Júlia Jarne-Ferrer (Author), Christian Griñán-Ferré (Author), Aina Bellver-Sanchis (Author), Santiago Vázquez (Author), Diego Muñoz-Torrero (Author), Mercè Pallàs (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
Published: (2020) -
Inhibition of Soluble Epoxide Hydrolase for Renal Health
by: Jun-Yan Liu, et al.
Published: (2019) -
Soluble epoxide hydrolase in the human placenta throughout gestation
by: Tai-Ho Hung, et al.
Published: (2019) -
Association between the soluble epoxide hydrolase gene and preeclampsia
by: Ismail Sari, et al.
Published: (2017) -
The impact of the soluble epoxide hydrolase cascade on periodontal tissues
by: Henrique Ballassini Abdalla, et al.
Published: (2023)